Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bausch & Lomb Incorporated
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Voluntarily provide written informed consent
≥18 years of age
Subject-reported history of DED OU for at least 6 months
Same eye satisfies the criteria for dry eye signs at both screening and baseline/randomization
The criteria for dry eye symptoms are met at both screening and baseline/randomization
As needed (PRN) or scheduled use of non-prescription (OTC) artificial tear, gels, or lubricants for symptoms of dry eye within the past 30 days
Able and willing to follow instructions, including participation in all trial assessments and visits
You may not be if
Known allergy or sensitivity to any study treatment (or any of its components)
Best-corrected visual acuity (BCVA) of 0.7 logarithm of the minimum angle of resolution (logMAR) or worse (50 Early Treatment Diabetic Retinopathy Study \[ETDRS\] letters; Snellen equivalent score of 20/100 or worse) at Visit 1 (Screening) or Visit 2 (baseline/randomization)
Any clinically significant (CS) ocular surface slit-lamp findings at Visit 1 (Screening) or Visit 2 (baseline/randomization), or findings that may interfere with trial parameters in the opinion of the Investigator.
Use of any of any ocular therapies within 30 days.
Unable or unwilling to stop current topical dry eye treatments
